UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 161

Sortiert nach

A multicentre, open-label, phase-I/randomised phase-II study to evaluate safety, pharmacokinetics, and efficacy of nintedanib vs. sorafenib in European patients with advanced hepatocellular carcinoma

British journal of cancer, 2018-05, Vol.118 (9), p.1162-1168

2018

Link zum Volltext

Verfügbarkeit prüfen

A randomized, double-blind, placebo-controlled phase II study to assess the efficacy and safety of mapatumumab with sorafenib in patients with advanced hepatocellular carcinoma

Annals of oncology, 2016-04, Vol.27 (4), p.680-687

2016

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of a nanofiltered liquid intravenous immunoglobulin product in patients with primary immunodeficiency and idiopathic thrombocytopenic purpura

Vox sanguinis, 2011-08, Vol.101 (2), p.138-146

2011

Link zum Volltext

Verfügbarkeit prüfen

6504 ORAL Safety and Efficacy of Epirubicin, Cisplatin, and Capecitabine (ECX) Plus Rilotumumab (R) as First-line Treatment for Unresectable Locally Advanced (LA) or Metastatic (M) Gastric or Esophagogastric Junction (EGJ) Adenocarcinoma

European journal of cancer (1990), 2011, Vol.47, p.S443-S443

2011

Link zum Volltext

Verfügbarkeit prüfen

Clinicopathological characteristics of metaplastic breast cancer – analysis of the basic immunohistochemical profile and comparison with other invasive breast cancer types

Breast (Edinburgh), 2019-02, Vol.43, p.135-141

2019

Link zum Volltext

Verfügbarkeit prüfen

Radioimmunotherapy with Y-ibritumomab tiuxetan is a safe and efficient treatment for patients with B-cell lymphoma relapsed after auto-SCT: an analysis of the international RIT-Network

Bone marrow transplantation (Basingstoke), 2011-06, Vol.46 (6), p.901-903

2011

Link zum Volltext

Verfügbarkeit prüfen

Effects of the flavonoid baicalin and its metabolite baicalein on androgen receptor expression, cell cycle progression and apoptosis of prostate cancer cell lines

Cell proliferation, 2001-10, Vol.34 (5), p.293-304

2001

Link zum Volltext

Verfügbarkeit prüfen

A randomized, open‐label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia

British journal of haematology, 2014-11, Vol.167 (4), p.466-477

2014

Link zum Volltext

Verfügbarkeit prüfen

P-57 Effectiveness and safety of trifluridine/tipiracil in patients with metastatic colorectal cancer in clinical practice in Poland

Annals of oncology, 2020-07, Vol.31, p.S108

2020

Link zum Volltext

Verfügbarkeit prüfen

Differences in induction of p53, p21WAF1 and apoptosis in relation to cell cycle phase of MCF-7 cells treated with camptothecin

International journal of oncology, 1999-11, Vol.15 (5), p.861

1999

Link zum Volltext

Verfügbarkeit prüfen

Induction of apoptosis in bone marrow cells after treatment of mice with WR-2721 and gamma-rays: Relationship to the cell cycle

Cell biology and toxicology, 2003-02, Vol.19 (1), p.13-27

2003

Link zum Volltext

Verfügbarkeit prüfen

Potentiation of tumor necrosis factor induced apoptosis by onconase

International journal of oncology, 1998-07, Vol.13 (1), p.11

1998

Link zum Volltext

Verfügbarkeit prüfen

Congenital anomalies of the genitourinary system can help in diagnosis of the primary site of metastatic cancer: a case report and a review of the literature

OncoTargets and therapy, 2016-07, Vol.2016 (Issue 1), p.4435-4440

2016

Link zum Volltext

Verfügbarkeit prüfen

Effects of WR-2721 and cyclophosphamide on the cell cycle phase specificity of apoptosis in mouse bone marrow

Anti-cancer drugs, 2002-08, Vol.13 (7), p.751-758

2002

Link zum Volltext

Verfügbarkeit prüfen

Updated Efficacy, Biomarker, and Exposure-Response Data from a Phase 2 Study of Rilotumumab (R) Plus Epirubicin, Cisplatin, and Capecitabine (ECX) in Gastric (G) or Esophagogastric Junction (EGJ) Cancer

Annals of oncology, 2012-09, Vol.23, p.ix230

2012

Link zum Volltext

Verfügbarkeit prüfen

687P - Updated Efficacy, Biomarker, and Exposure-Response Data from a Phase 2 Study of Rilotumumab (R) Plus Epirubicin, Cisplatin, and Capecitabine (ECX) in Gastric (G) or Esophagogastric Junction (EGJ) Cancer

Annals of oncology, 2012-09, Vol.23, p.ix230-ix230

2012

Link zum Volltext

Verfügbarkeit prüfen

Unique analytical capabilities of laser scanning cytometry (LSC) that complement flow cytometry

Folia histochemica et cytobiologica, 2001, Vol.39 (2), p.87

2001

Link zum Volltext

Verfügbarkeit prüfen

PD-005 Combined analysis of two randomised Phase II trials comparing the efficacy and safety of nintedanib versus sorafenib in Caucasian and Asian patients with advanced hepatocellular carcinoma

Annals of oncology, 2015-06, Vol.26, p.iv102

2015

Link zum Volltext

Verfügbarkeit prüfen

Telomerase Expression and Activity are Coupled with Myocyte Proliferation and Preservation of Telomeric Length in the Failing Heart

Proceedings of the National Academy of Sciences - PNAS, 2001-07, Vol.98 (15), p.8626-8631

2001

Link zum Volltext

Verfügbarkeit prüfen

Long-term follow-up of efficacy of irinotecan-based chemotherapy in poor-risk patients suffering from metastatic colorectal cancer

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e14102-e14102

2010

Link zum Volltext

Verfügbarkeit prüfen

Analysis of long-term outcome and late toxicity in Hodgkin lymphoma survivors

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.19537-19537

2008

Link zum Volltext

Verfügbarkeit prüfen

AMG 386 in combination with sorafenib in patients (pts) with metastatic renal cell cancer (mRCC): A randomized, double-blind, placebo-controlled, phase II study

Journal of clinical oncology, 2011-03, Vol.29 (7_suppl), p.309-309

2011

Link zum Volltext

Verfügbarkeit prüfen

Radioimmunotherapy with super(90)Y-ibritumomab tiuxetan is a safe and efficient treatment for patients with B-cell lymphoma relapsed after auto-SCT: an analysis of the international RIT-Network

Bone marrow transplantation (Basingstoke), 2011-06, Vol.46 (6), p.901-903

2011

Link zum Volltext

Verfügbarkeit prüfen

Use of radioimmunotherapy for consolidation for chemosensitive mantle cell lymphoma (MCL): Summary of International Radioimmunotherapy Registry data

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e18519-e18519

2010

Link zum Volltext

Verfügbarkeit prüfen

Male breast cancer: An analysis of clinical features, disease outcome and treatment efficacy

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.11539-11539

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 161

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(143)
Mit Volltextzugriff
(134)

Publikationsform

Artikel
(160)
Berichte
(1)

Sprache

Englisch
(141)
Polnisch
(36)
Deutsch
(1)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(78)
Life Sciences & Biomedicine
(77)
Humans
(63)
Oncology
(32)
Female
(30)
Male
(28)
Adult
(23)
Middle Aged
(21)
Cancer
(18)
Aged
(17)
Poland
(16)
Chemotherapy
(14)
Diagnosis
(13)
Tumors
(13)
Cancer Therapies
(12)
Pancreatic Cancer
(12)
Patients
(12)
Public, Environmental & Occupational Health
(12)
Quality Of Life
(12)
General & Internal Medicine
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A multicentre, open-label, phase-I/randomised phase-II study to evaluate safety, pharmacokinetics, and efficacy of nintedanib vs. sorafenib in European patients with advanced hepatocellular carcinoma

A randomized, double-blind, placebo-controlled phase II study to assess the efficacy and safety of mapatumumab with sorafenib in patients with advanced hepatocellular carcinoma

Efficacy and safety of a nanofiltered liquid intravenous immunoglobulin product in patients with primary immunodeficiency and idiopathic thrombocytopenic purpura

6504 ORAL Safety and Efficacy of Epirubicin, Cisplatin, and Capecitabine (ECX) Plus Rilotumumab (R) as First-line Treatment for Unresectable Locally Advanced (LA) or Metastatic (M) Gastric or Esophagogastric Junction (EGJ) Adenocarcinoma

Clinicopathological characteristics of metaplastic breast cancer – analysis of the basic immunohistochemical profile and comparison with other invasive breast cancer types

Radioimmunotherapy with Y-ibritumomab tiuxetan is a safe and efficient treatment for patients with B-cell lymphoma relapsed after auto-SCT: an analysis of the international RIT-Network

Effects of the flavonoid baicalin and its metabolite baicalein on androgen receptor expression, cell cycle progression and apoptosis of prostate cancer cell lines

A randomized, open‐label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia

P-57 Effectiveness and safety of trifluridine/tipiracil in patients with metastatic colorectal cancer in clinical practice in Poland

Differences in induction of p53, p21WAF1 and apoptosis in relation to cell cycle phase of MCF-7 cells treated with camptothecin

Induction of apoptosis in bone marrow cells after treatment of mice with WR-2721 and gamma-rays: Relationship to the cell cycle

Potentiation of tumor necrosis factor induced apoptosis by onconase

Congenital anomalies of the genitourinary system can help in diagnosis of the primary site of metastatic cancer: a case report and a review of the literature

Effects of WR-2721 and cyclophosphamide on the cell cycle phase specificity of apoptosis in mouse bone marrow

Updated Efficacy, Biomarker, and Exposure-Response Data from a Phase 2 Study of Rilotumumab (R) Plus Epirubicin, Cisplatin, and Capecitabine (ECX) in Gastric (G) or Esophagogastric Junction (EGJ) Cancer

687P - Updated Efficacy, Biomarker, and Exposure-Response Data from a Phase 2 Study of Rilotumumab (R) Plus Epirubicin, Cisplatin, and Capecitabine (ECX) in Gastric (G) or Esophagogastric Junction (EGJ) Cancer

Unique analytical capabilities of laser scanning cytometry (LSC) that complement flow cytometry

PD-005 Combined analysis of two randomised Phase II trials comparing the efficacy and safety of nintedanib versus sorafenib in Caucasian and Asian patients with advanced hepatocellular carcinoma

Telomerase Expression and Activity are Coupled with Myocyte Proliferation and Preservation of Telomeric Length in the Failing Heart

Long-term follow-up of efficacy of irinotecan-based chemotherapy in poor-risk patients suffering from metastatic colorectal cancer

Analysis of long-term outcome and late toxicity in Hodgkin lymphoma survivors

AMG 386 in combination with sorafenib in patients (pts) with metastatic renal cell cancer (mRCC): A randomized, double-blind, placebo-controlled, phase II study

Radioimmunotherapy with super(90)Y-ibritumomab tiuxetan is a safe and efficient treatment for patients with B-cell lymphoma relapsed after auto-SCT: an analysis of the international RIT-Network

Use of radioimmunotherapy for consolidation for chemosensitive mantle cell lymphoma (MCL): Summary of International Radioimmunotherapy Registry data

Male breast cancer: An analysis of clinical features, disease outcome and treatment efficacy

Suchergebnisse filtern